Avestria: Linda Greub on the Long Road to the Right Partners

<p>Linda Greub is the Co-Founder and General Partner at Avestria Ventures, a venture capital firm dedicated to women’s health and empowering females in the field of life science. Linda comes to this role with over twenty years of experience in investment and operations. She has worn many professional hats, including institutional investor, corporate M&A executive, a hedge fund analyst, and a private venture investor. Before joining Avestria, Linda was a partner at LMN Ventures, and also served as the CEO of Muir Partners, VP of Corporate Development at RainDance Technologies, and VP of Strategy and Corporate Development at Singulex, among other roles. She earned her MBA from Harvard Business School and has invested over $3.2 billion of equity capital and has raised over $1.8 billion of capital for public companies, including work with Bank of America Securities, Pacific Growth Equities, Tudor Investments, and Essex Investment Management.</p> <p> </p> <p>Linda joins me today to share insight on her venture capital firm Avestria and the company’s current portfolio. She shares overlooked aspects of the health care system when it comes to women, including health issues that women are more susceptible to than men. Linda discusses different factors that go into going out on your own in business and how she met her co-founder. Linda also highlights what types of companies Avestria does and doesn’t invest in and shares her words of wisdom for start-ups when pitching a product or service.</p> <p> </p> <p>“There is absolutely no reason that women shouldn’t be doing as well or better than men as entrepreneurs in the healthcare and life science field.” - Linda Greub</p> <p align="center"> </p> <p><strong>Today on When She Founded:</strong></p> <p> </p> <ul> <li>Insight into Linda’s background, her venture capital firm Avestria, and the two “buckets” Avestria invests in</li> <li>A unique perspective that female venture capitalists can bring to the table, especially in the realm of women’s health issues</li> <li>The percentage